OM:BIOG BBiotechs
Is BioGaia (OM:BIOG B) Undervalued Following Strong Q2 Earnings?
Why BioGaia Stock Is In Focus After Q2 Earnings
BioGaia (OM:BIOG B) is drawing attention after reporting second quarter 2026 results, with sales of SEK 440.86 million and net income of SEK 103.16 million, both above the figures reported a year earlier.
For the first six months of 2026, BioGaia reported sales of SEK 813.41 million and net income of SEK 182.57 million, alongside basic earnings per share from continuing operations of SEK 1.8, compared with SEK 1.66 in the same period last...